# Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy

> **NCT01772160** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 395 (actual)

## Conditions studied

- Herpes Zoster
- Herpes Zoster Vaccine

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT01772160
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02-26
- **Primary completion:** 2016-10-05
- **Final completion:** 2016-10-05
- **Target enrollment:** 395 (ACTUAL)
- **Last updated:** 2020-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01772160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01772160, "Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01772160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*